Jilin Aodong Pharmaceutical Group Co Ltd (000623) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Jilin Aodong Pharmaceutical Group Co., Ltd. manufactures and sells pharmaceutical products in China.

Total Assets Chart for Jilin Aodong Pharmaceutical Group Co Ltd

Jilin Aodong Pharmaceutical Group Co Ltd (000623) total assets for FY2025 were CNY 34.4B, a 4.3% change from FY2024. Jilin Aodong Pharmaceutical Group Co Ltd's total assets grew from CNY 206.4M in 1993 to CNY 34.4B in 2025 (16574.0% over 32 years). Total assets compound annual growth rate: 5-year CAGR of 4.7%, 10-year CAGR of 5.7%, 20-year CAGR of 14.0%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (CNY)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
¥22.27B
Implied Share Price
¥18.62
Enterprise Value
¥21.69B
Revenue (TTM)
¥2.23B
EBITDA
¥38.93M
Profit Margin
123.25%
Trailing P/E
7.96
Forward P/E
14.62
Price/Book (MRQ)
0.71
Price/Sales (TTM)
10.00
EV/EBITDA
7.70
EV/Revenue
9.74
Dividend Yield
2.68%
Book Value
¥26.86
Free Cash Flow (FY2025)
¥143.81M
Free Cash Flow Yield
0.65%

Snapshot as of 28th August 2026 — not point-in-time controlled, may lag the live market by a few days.